6 citations as recorded by crossref.

1. Exploring serum miR-33b as a novel diagnostic marker for hypercholesterolemia and obesity: insights from a pilot case-control study Y. Masoumi-Ardakani et al. https://doi.org/10.1186/s12902-025-01849-9
2. The Role of Cholesterol Metabolism and Its Regulation in Tumor Development Y. Wu et al. https://doi.org/10.1002/cam4.70783
3. Circulating and Exosomal microRNA-33 in Childhood Obesity M. Cabiati et al. https://doi.org/10.3390/biomedicines11082295
4. Non-coding RNA networks in metabolic dysfunction-associated steatotic liver disease: Mechanisms and therapeutic perspectives R. Ren et al. https://doi.org/10.1016/j.livres.2026.05.002
5. Doxorubicin inhibits cholesterol efflux through the miR-33/ABCA1 pathway F. Zhu et al. https://doi.org/10.1016/j.bbrc.2023.01.024
6. MiR−33 as a novel diagnostic biomarker for distinguishing cholesterol from adenomatous polyps: a case-control study X. Hu et al. https://doi.org/10.1186/s41065-025-00407-6